These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10936742)

  • 21. Comparison of two continuous combined estrogen progestogen regimens in postmenopausal women: a randomized trial.
    AinMelk Y
    Fertil Steril; 1996 Dec; 66(6):962-8. PubMed ID: 8941062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of hormone replacement therapy on perceptual and cognitive event-related potentials in menopausal insomnia.
    Anderer P; Semlitsch HV; Saletu B; Saletu-Zyhlarz G; Gruber D; Metka M; Huber J; Gräser T; Oettel M
    Psychoneuroendocrinology; 2003 Apr; 28(3):419-45. PubMed ID: 12573306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness, tolerability and acceptance of a low-dosed estradiol/dienogest formulation (Lafamme 1 mg/2 mg) for the treatment of menopausal complaints: a non-interventional observational study over 6 cycles of 28 days.
    Rouskova D; Mittmann K; Schumacher U; Dietrich H; Zimmermann T
    Gynecol Endocrinol; 2015 Jul; 31(7):560-4. PubMed ID: 26217921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endometrial effects during hormone replacement therapy with a sequential oestradiol valerate/cyproterone acetate preparation.
    Koninckx PR; Lauweryns JM; Cornillie FJ
    Maturitas; 1993 Mar; 16(2):97-110. PubMed ID: 8387151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): a Phase III trial.
    Palacios S; Wildt L; Parke S; Machlitt A; Römer T; Bitzer J
    Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):57-62. PubMed ID: 19969409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative study between estradiol valerate combined with cyproterone acetate, and conjugated equine estrogens combined with medroxyprogesterone acetate as hormone replacement therapy in climacteric].
    Carranza-Lira S; Martínez-Chéquer JC; Río de la Loza F; Murillo-Uribe A; Celis C
    Ginecol Obstet Mex; 2000 Nov; 68():442-7. PubMed ID: 11195956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, double-blind, multicentre study comparing the clinical effects of two sequential estradiol-progestin combinations containing either desogestrel or norethisterone acetate in climacteric women with estrogen deficiency symptoms.
    Saure A; Hirvonen E; Milsom I; Christensen A; Damber MG
    Maturitas; 1996 May; 24(1-2):111-8. PubMed ID: 8794442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contraception containing estradiol valerate and dienogest--advantages, adherence and user satisfaction.
    Graziottin A
    Minerva Ginecol; 2014 Oct; 66(5):479-95. PubMed ID: 25245997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of oral and transdermal hormonal replacement treatment containing levonorgestrel.
    Paoletti AM; Pilloni M; Orrù M; Floris S; Pistis M; Guerriero S; Ajossa S; Melis GB
    Maturitas; 2002 Jun; 42(2):137-47. PubMed ID: 12065173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bleeding pattern and climacteric symptoms during different sequential combined HRT regimens in current use.
    Marslew U; Munk-Nielsen N; Nilas L; Riis BJ; Christiansen C
    Maturitas; 1994 Oct; 19(3):225-37. PubMed ID: 7799829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined oral estradiol valerate-norethisterone treatment over three years in postmenopausal women. 1. Clinical aspects and endometrial histology.
    Perry W; Wiseman RA; Cullen NM
    Gynecol Endocrinol; 1998 Apr; 12(2):109-22. PubMed ID: 9610424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progestational effects of combinations of gestodene on the postmenopausal endometrium during hormone replacement therapy.
    Byrjalsen I; Bjarnason NH; Christiansen C
    Am J Obstet Gynecol; 1999 Mar; 180(3 Pt 1):539-49. PubMed ID: 10076125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
    Endrikat J; Graeser T; Mellinger U; Ertan K; Holz C
    Maturitas; 2007 Oct; 58(2):201-7. PubMed ID: 17889463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women.
    Heikkinen J; Kyllönen E; Kurttila-Matero E; Wilén-Rosenqvist G; Lankinen KS; Rita H; Väänänen HK
    Maturitas; 1997 Mar; 26(2):139-49. PubMed ID: 9089564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing continuous-combined hormone replacement therapy for postmenopausal women: a comparison of six different treatment regimens.
    Heikkinen JE; Vaheri RT; Ahomäki SM; Kainulainen PM; Viitanen AT; Timonen UM
    Am J Obstet Gynecol; 2000 Mar; 182(3):560-7. PubMed ID: 10739508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect on biochemical vasoactive markers during postmenopausal hormone replacement therapy: estradiol versus estradiol/dienogest.
    Mueck AO; Seeger H; Lüdtke R; Gräser T; Wallwiener D
    Maturitas; 2001 May; 38(3):305-13. PubMed ID: 11358648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of a sequential combination of estradiol valerate and cyproterone acetate on the functional properties of the arterial wall in menopausal women].
    Mares P; Dauzat M; Abramovici Y; Deklunder G; Body G; Crepin G; Denis A; Favier M
    Gynecol Obstet Fertil; 2000; 28(7-8):509-17. PubMed ID: 10996962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of percutaneous oestradiol gels in postmenopausal hormone replacement therapy on clinical symptoms and endometrium.
    Foidart JM; Béliard A; Hedon B; Ochsenbein E; Bernard AM; Bergeron C; Thomas JL
    Br J Obstet Gynaecol; 1997 Mar; 104(3):305-10. PubMed ID: 9091006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of heavy menstrual bleeding with the estradiol valerate and dienogest oral contraceptive pill.
    Micks EA; Jensen JT
    Adv Ther; 2013 Jan; 30(1):1-13. PubMed ID: 23239397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estradiol valerate/dienogest: a novel oral contraceptive.
    Whalen KL; Rose R
    Ann Pharmacother; 2011 Oct; 45(10):1256-61. PubMed ID: 21917554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.